׳¦׳׳˜

הידעת? הדפדפן שהינך גולש ממנו אינו עדכני

הדפדפן שהינך גולש ממנו אינו עדכני ויתכן שהאתר אינו יעבוד בצורה טובה. הדפדפנים הנתמכים באתר הם:

לחץ על האיקונים למעבר לדף ההורדה של הדפדפן

סגירת חלונית אל תציג בשנית

בסגירת החלונית תועבר/י לאתר מותאם לדפדפן ויתכן כי חלק מהאתר לא יעבוד בצורה מיטבית

Moshe Rogosnitzky

הדפסה דוא

CDR - Center for Drug Repurposing

Biography

Moshe Rogosnitzky is the Director of the Center for Drug Repurposing at Ariel University. As co-founder of the nonprofit MedInsight® Research Institute, he has spent his career advancing the field of personalized medicine and successfully innovating new uses for existing drugs. His discoveries have benefited hundreds of thousands of patients, and his scholarly publications span a wide range of subjects including: liver, pancreatic, breast and prostate cancers, Crohn’s disease, eye disorders, gastrointestinal and abdominal surgeries, and hemostasis. Moshe is an editorial board member of the journal Drug Repurposing, Rescue and Repositioning.

Visit Moshe's Blog

View on LinkedIn

Publications

Hurst WJ, M Rogosnitzky, PJ McLaughlin, and IS Zagon. The stability of opioid growth factor ([Met5]-enkephalin) in solution using HPLC and photodiode array detection. J. Liquid Chromatography & Related Technologies, 2006; 29:1-7.

Smith JP, Stock H, Bingaman S, Mauger D, Rogosnitzky M, Zagon IS. Low-dose naltrexone therapy improves active Crohn's disease. Am J Gastroenterol. 2007 Apr;102(4):820-8.

Zagon I, Donahue RN, Rogosnitzky M, McLaughlin PJ. Imiquimod Upregulates the Opioid Growth Factor Receptor to Inhibit Cell Proliferation Independent of Immune Function. Exp Biol Med (Maywood). 2008;233: 968-979.

Barken I, Geller J, Rogosnitzky M. Noscapine inhibits human prostate cancer progression and metastasis in a mouse model. Anticancer Res. 2008;28(6A):3701-3704.

Barken I, Geller J, Rogosnitzky M. Prophylactic noscapine inhibits prostate cancer in a mouse model. Anticancer Res. 2010;30(2):399-401.

Rogosnitzky M, Danks R Validation of blood testing for K-ras mutations in colorectal and pancreatic cancer. A short review. Anticancer Res. 2010;30(7):2943-2947.

PJ McLaughlin, M Rogosnitzky and IS Zagon Inhibition of DNA synthesis in mouse epidermis by topical imiquimod is dependent on opioid receptors. Exp Biol Med (Maywood). 2010;235(11): 1292-99.

Rogosnitzky M, Danks R The therapeutic potential of the biscoclaurine alkaloid, cepharanthine, for a range of clinical conditions (review). Pharmacological Reports 2011;63, 337-347.

Goodley PH, Rogosnitzky M. The Effect of Gallium Nitrate on Arresting Blood Flow from a Wound. Case Rep Med. 2011; 2011:819710.

Rogosnitzky M, Danks R, Holt D. Intravenous Immunoglobulin for the treatment of Crohn's disease (review). Autoimmun Rev. 2012 Dec;12(2):275-80.

Rogosnitzky M, Danks R, Kardash E. Therapeutic Potential of Tranilast, an Anti-allergy Drug, in Proliferative Disorders (review). Anticancer Res. 2012;32(7):2471-2478.

Rogosnitzky M, Finegold MJ, McLauglin PJ, Zagon IS. Opioid growth factor (OGF) for hepatoblastoma: a novel non-toxic treatment. Invest New Drugs. 2013 Aug;31(4):1066-70.

A Bauters, DJ Holt, P Zerbib, M Rogosnitzky. Gallium nitrate induces fibrinogen flocculation: an explanation for its hemostatic effect? Biometals. 2013 Dec;26(6):935-9.

Lebas A, Rogosnitzky M, Chater C, Colombel JF, Nachury M, Cortot A, and Zerbib Ph. Efficacy of sacral nerve stimulation for poor functional results of J-Pouch ileoanal anastomosis: a pilot study. Techniques in Coloproctology. 2014 Apr;18(4):355-60.

Anne Bauters, Moshe Rogosnitzky, Eric Hachulla, Marie-Christine Copin, Alain Saudemont, Philippe Zerbib. Elevated plasma fibrinogen in clinically asymptomatic unicentric Castleman’s disease: a case report. J Clin Exp Hematop. 2014;54(1):85-8.

Ph Zerbib, R Caiazzo, G Piessen, M Rogosnitzky, C Séquier, D Koriche, S Truant, E Boleslawski, J-P Chambon, F Pruvot. Outcome in porcine acellular dermal matrix reinforcement of infected abdominal wall defects – a prospective study. Hernia. 2013 Sep 19.

Zerbib P, Vinet A, Rogosnitzky M, Truant S, Chambon JP, Pruvot FR. Gastrocele Complicates the Course of Non-operated Severe Caustic Injuries: Operative Strategies. World J. Surg, 2014 May:38(5): 1233-7.

Dalgleish A, Featherstone P, Vlassov V, Rogosnitzky M. Rituximab for treating CD20+ prostate cancer with generalized lymphadenopathy: a case report and review of the literature. Invest New Drugs. 2014 Oct;32(5):1048-52.

Carlock BH, Bienstock CA, Rogosnitzky M. Pterygium: nonsurgical treatment using topical dipyrdiamole - a case report. Case Rep Ophthalmol. 2014 Mar 25;5(1):98-103.

Rogosnitzky Moshe, Isakov Itzhak, Wlassoff Wjatschesslaw, Ingram April, and Barishak Y. Robert. Ocular Applications of Dipyridamole: A Review of Indications and Routes of Administration. Journal of Ocular Pharmacology and Therapeutics. 2015; 32(2):83-9.

Raynaud K, Seguy D, Rogosnitzky M, Saulnier F, Pruvot FR, Zerbib Ph. Conservative management of severe caustic injuries during acute phase leads to superior long-term nutritional and quality of life (QoL) outcome. Langebecks Arch Surg. 2016; 401(1):81-7.

Rogosnitzky M. and Branch S. Gadolinium-Based Contrast Agent Toxicity- A Review of Known and Proposed Mechanisms. BioMetals. 2016; 29(3), 365-376.

Book Chapters

Moshe Rogosnitzky and Rachel Danks (2012). Testosterone for the Treatment of Mammary and Prostate Cancers: Historical Perspectives and New Directions, Advances in Cancer Management, Ravinder Mohan (Ed.), ISBN: 978-953-307-870-0

Abstracts

Moshe Rogosnitzky, Carol A Bienstock, Yitzchak Issakov, Aaron Frenkel. Topical Dipyridamole for Treatment of Pterygium and Associated Dry Eye Symptoms: Analysis of UserReported Outcomes. ISVER Conference Proceedings, 2016.

Raynaud, Kevin, Benoit Voisin, Dine Koriche, Moshe Rogosnitzky, Fabienne Saulnier, François-René Pruvot, Jean-Pierre Chambon, and Philippe Zerbib. "Sa1953 Severe Gastric Caustic Injuries (SGCI)-Conservative Management During Acute Phase Leads to Superior Long-Term Quality of Life (QOL) and Nutritional Outcome." Gastroenterology 144, no. 5 (2013): S-343

T. Armaghany, G. Vahdati, S. Broline, R. Goshen, M. Rogosnitzky, E. Delpassand. Dramatic response with Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE and Capecitabine in the treatment of metastatic Thymic carcinoma. Poster presentation/abstract presented at the Theranostics World Conference March 2015.

עדכון אחרון ב-רביעי, 01 יוני 2016 15:53
 

ברוכים הבאים לאתר אוניברסיטת אריאל בשומרון לכל צורכי הנגישות יש ללחוץ על כפתור הנגישות למעלה